TCCR Stock Price, News & Analysis
Company Description
TCCR (OTC: TCCR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $52.0M.
TCCR stock has gained 36.4% over the past year.
This page provides a comprehensive overview of TCCR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TCCR (TCCR) stock. Over the past 12 months, the stock has gained 36.4%. At a market capitalization of $52.0M, TCCR is classified as a micro-cap stock with approximately 34.6M shares outstanding.
Latest News
TCCR has 8 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings, management, acquisition. View all TCCR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TCCR Company Profile & Sector Positioning
TCCR (TCCR) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing TCCR often look at related companies in the same sector, including JUPITER NEUROSCIENCES, INC. (JUNS), Bioxcel Therapeutics Inc (BTAI), Vtv Therapeutics (VTVT), Actinium Pharmac (ATNM), and Inmune Bio Inc (INMB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TCCR's relative position within its industry.